FOCUS’s Pharmaceutical Services Investment Banking team partners with owners and management teams to translate these dynamics into premium transaction outcomes. Through rigorous financial modeling, thoughtful positioning, and a disciplined, confidential marketing process, our bankers help pharmaceutical services companies attract strong interest from private equity and strategic buyers, increasing value while identifying partners aligned with long-term growth and innovation goals.
Pharmaceutical innovation is accelerating, and the infrastructure that supports it has never been more critical. As biopharma companies increasingly outsource development, manufacturing, and market-launch functions, pharmaceutical services businesses have emerged as essential partners across the drug lifecycle. This shift has driven sustained private equity interest in Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs), ambulatory infusion centers, and specialty pharmacies, particularly those positioned to support high-growth areas such as cell and gene therapy and other highly tailored treatments.
